These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

519 related articles for article (PubMed ID: 17604826)

  • 1. Dynamic regulation of MTHFR mRNA expression and C677T genotype modulate mortality in coronary artery disease patients after revascularization.
    Pereira AC; Miyakawa AA; Lopes NH; Soares PR; de Oliveira SA; Cesar LA; Ramires JF; Hueb W; Krieger JE
    Thromb Res; 2007; 121(1):25-32. PubMed ID: 17604826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C677T polymorphism of the methylenetetrahydrofolate reductase gene is a risk factor of adverse events after coronary revascularization.
    Botto N; Andreassi MG; Rizza A; Berti S; Bevilacqua S; Federici C; Palmieri C; Glauber M; Biagini A
    Int J Cardiol; 2004 Sep; 96(3):341-5. PubMed ID: 15301885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene--nutrition interactions in coronary artery disease: correlation between the MTHFR C677T polymorphism and folate and homocysteine status in a Korean population.
    Huh HJ; Chi HS; Shim EH; Jang S; Park CJ
    Thromb Res; 2006; 117(5):501-6. PubMed ID: 15935452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylenetetrahydrofolate reductase gene, homocysteine and coronary artery disease: the A1298C polymorphism does matter. Inferences from a case study (Madeira, Portugal).
    Freitas AI; Mendonça I; Guerra G; Brión M; Reis RP; Carracedo A; Brehm A
    Thromb Res; 2008; 122(5):648-56. PubMed ID: 18384842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of number of vessels disease on outcome of patients with stable coronary artery disease: 5-year follow-up of the Medical, Angioplasty, and bypass Surgery study (MASS).
    Lopes NH; Paulitsch Fda S; Gois AF; Pereira AC; Stolf NA; Dallan LO; Ramires JA; Hueb WA
    Eur J Cardiothorac Surg; 2008 Mar; 33(3):349-54. PubMed ID: 18249128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C677T mutation of methylenetetrahydrofolate reductase gene and serum homocysteine levels in Turkish patients with coronary artery disease.
    Yilmaz H; Isbir S; Agachan B; Ergen A; Farsak B; Isbir T
    Cell Biochem Funct; 2006; 24(1):87-90. PubMed ID: 15648053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylenetetrahydrofolate reductase gene C677T polymorphism, homocysteine, vitamin B12, and DNA damage in coronary artery disease.
    Andreassi MG; Botto N; Cocci F; Battaglia D; Antonioli E; Masetti S; Manfredi S; Colombo MG; Biagini A; Clerico A
    Hum Genet; 2003 Feb; 112(2):171-7. PubMed ID: 12522558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of the MTHFR C677T and A1298C polymorphisms on survival in patients with advanced CKD and ESRD: a prospective study.
    Jamison RL; Shih MC; Humphries DE; Guarino PD; Kaufman JS; Goldfarb DS; Warren SR; Gaziano JM; Lavori P;
    Am J Kidney Dis; 2009 May; 53(5):779-89. PubMed ID: 19272686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of MTHFR C677T genotype on survival in type 2 diabetes patients with end-stage diabetic nephropathy.
    Böger CA; Stubanus M; Haak T; Götz AK; Christ J; Hoffmann U; Riegger GA; Krämer BK
    Nephrol Dial Transplant; 2007 Jan; 22(1):154-62. PubMed ID: 17005529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperhomocysteinaemia, methylenetetrahydrofolate reductase polymorphism and risk of coronary artery disease.
    Kerkeni M; Addad F; Chauffert M; Myara A; Gerhardt M; Chevenne D; Trivin F; Farhat MB; Miled A; Maaroufi K
    Ann Clin Biochem; 2006 May; 43(Pt 3):200-6. PubMed ID: 16704755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An association between the methylenetetrahydrofolate reductase (MTHFR) C677T mutation and inflammation markers related to cardiovascular disease.
    Dedoussis GV; Panagiotakos DB; Pitsavos C; Chrysohoou C; Skoumas J; Choumerianou D; Stefanadis C;
    Int J Cardiol; 2005 Apr; 100(3):409-14. PubMed ID: 15837084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of chronic kidney disease with clinical outcomes after coronary revascularization: the Arterial Revascularization Therapies Study (ARTS).
    Ix JH; Mercado N; Shlipak MG; Lemos PA; Boersma E; Lindeboom W; O'Neill WW; Wijns W; Serruys PW
    Am Heart J; 2005 Mar; 149(3):512-9. PubMed ID: 15864241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An association of 5,10-methylenetetrahydrofolate reductase (MTHFR) gene polymorphism and common carotid atherosclerosis.
    Kawamoto R; Kohara K; Tabara Y; Miki T; Doi T; Tokunaga H; Konishi I
    J Hum Genet; 2001; 46(9):506-10. PubMed ID: 11558898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperhomocysteinemia and mortality after coronary artery bypass grafting.
    Girelli D; Martinelli N; Olivieri O; Pizzolo F; Friso S; Faccini G; Bozzini C; Tenuti I; Lotto V; Villa G; Guarini P; Trabetti E; Pignatti PF; Mazzucco A; Corrocher R
    PLoS One; 2006 Dec; 1(1):e83. PubMed ID: 17183715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contribution of thermolabile methylenetetrahydrofolate reductase variant to total plasma homocysteine levels in healthy men and women. Inter99 (2).
    Husemoen LL; Thomsen TF; Fenger M; Jørgensen HL; Jørgensen T
    Genet Epidemiol; 2003 May; 24(4):322-30. PubMed ID: 12687650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The MTHFR CT polymorphism confers a high risk for stroke in both homozygous and heterozygous T allele carriers with Type 2 diabetes.
    Hermans MP; Gala JL; Buysschaert M
    Diabet Med; 2006 May; 23(5):529-36. PubMed ID: 16681562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of plasma homocysteine with serum interleukin-6 and C-peptide levels in patients with type 2 diabetes.
    Araki A; Hosoi T; Orimo H; Ito H
    Metabolism; 2005 Jun; 54(6):809-14. PubMed ID: 15931619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of interleukin-6 G-174C gene polymorphism on coronary artery disease, cardiovascular complications and mortality in dialysis patients.
    Aker S; Bantis C; Reis P; Kuhr N; Schwandt C; Grabensee B; Heering P; Ivens K
    Nephrol Dial Transplant; 2009 Sep; 24(9):2847-51. PubMed ID: 19349293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction between Mediterranean diet and methylenetetrahydrofolate reductase C677T mutation on oxidized low density lipoprotein concentrations: the ATTICA study.
    Pitsavos C; Panagiotakos D; Trichopoulou A; Chrysohoou C; Dedoussis G; Chloptsios Y; Choumerianou D; Stefanadis C
    Nutr Metab Cardiovasc Dis; 2006 Mar; 16(2):91-9. PubMed ID: 16487909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of glycoprotein IIIa PlA2 polymorphism on outcome of patients with stable coronary artery disease and effect of smoking.
    Lopes NH; Pereira AC; Hueb W; Soares PR; Lanz JR; Gersh BJ; de Oliveira S; Cesar LA; Ramires JF; Krieger JE
    Am J Cardiol; 2004 Jun; 93(12):1469-72. PubMed ID: 15194015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.